Contribution of five top whole-genome association signals to hypertension in Han Chinese

Journal of Human Hypertension

Volumn 25, Issue 4, 2011, Pages 278-280

  Niu, W Q ^a,b,c   Zhang, Y ^a,c   Ji, K D ^a,c   Gao, P J ^a,b,c   Zhu, D L ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Chinese Academy of Sciences   (China)

^c Shanghai Institute of Hypertension   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; PROTEIN SERINE THREONINE KINASE; SERINE THREONINE PROTEIN KINASE 39; SODIUM CHLORIDE COTRANSPORTER; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HUMAN; HYPOOSMOTIC STRESS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN PHOSPHORYLATION; SYSTOLIC BLOOD PRESSURE;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 9; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RISK ASSESSMENT; RISK FACTORS;

EID: 79952817130     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.114     Document Type: Article

References (10)

1. Wang Y, O'Connell JR, McArdle PF, Wade JB, Dorff SE, Shah SJ et al. From the Cover: whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 2009; 106: 226-231.
2. Duarte JD, Lobmeyer MT, Wang Z, Chapman AB, Gums JG, Langaee TY et al. Lack of association between polymorphisms in STK39, a putative thiazide response gene, and blood pressure response to hydrochlorothia-zide. Pharmacogenet Genomics 2010; 20: 516-519.
3. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G et al. Replicating genotype-phenotype associations. Nature 2007; 447: 655-660. (Pubitemid 46889722)
4. Niu W, Zhang Y, Ji K, Gu M, Gao P, Zhu D. Confirmation of top polymorphisms in hypertension genome wide association study among Han Chinese. Clin Chim Acta 2010; 411: 1491-1495.
5. Niu WQ, Zhang Y, Ji KD, Gao PJ, Zhu DL. Lack of association between alpha-adducin G460W polymorphism and hypertension: evidence from a case-control study and a meta-analysis. J Hum Hypertens 2010; 24: 467-474.
6. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 2005; 24: 2911-2935. (Pubitemid 41419179)
7. Khanna M, Park P, Zirvi M, Cao W, Picon A, Day J et al. Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors. Oncogene 1999; 18: 27-38. (Pubitemid 29060576)
8. Cunnington MS, Kay C, Avery PJ, Mayosi BM, Koref MS, Keavney B. STK39 polymorphisms and blood pressure: an association study in British Caucasians and assessment of cis-acting influences on gene expression. BMC Med Genet 2009; 10: 135.
9. Qi Y, Niu W, Zhou W, Hou S, Qiu C. Correlation between angiotensinogen gene polymorphisms and essential hypertension in Chinese population. J Hum Hypertens 2008; 22: 147-150.
10. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet 2003; 361: 1629-1641. (Pubitemid 36579003)